PDEX logo

Pro-Dex, Inc. (PDEX) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

PDEX, 47.95$ (piyasa değeri 157M) fiyatla Healthcare işi olan Pro-Dex, Inc.'i temsil ediyor. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 59/100 puan alıyor.

Son analiz: 9 Şub 2026
59/100 AI Puanı PD 157M Hacim 27K

Pro-Dex, Inc. (PDEX) Sağlık ve Boru Hattı Genel Bakışı

CEORichard Lee Van Kirk Jr.
Çalışanlar146
MerkezIrvine, CA, US
Halka Arz Yılı1986
SektörHealthcare

Pro-Dex, Inc. is a specialized medical device manufacturer focusing on powered surgical instruments, offering a notable research candidate due to its high profit margin of 15.7%, strategic market positioning, and innovative product offerings within the orthopedic and related surgical fields.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 9 Şub 2026

Yatırım Tezi

Pro-Dex presents a notable research candidate due to its specialized market position and strong financial performance. With a P/E ratio of 11.31 and a healthy profit margin of 15.7%, the company demonstrates efficient profitability. The increasing demand for minimally invasive surgical procedures, coupled with Pro-Dex's focus on innovative powered surgical instruments, positions it for sustained growth. Key value drivers include expanding its product offerings within the orthopedic and craniomaxillofacial markets and leveraging its engineering and regulatory consulting services to deepen OEM partnerships. The company's beta of -0.02 indicates low volatility, making it a noteworthy option for risk-averse investors seeking stable returns within the healthcare sector. Upcoming product launches and strategic partnerships could further accelerate revenue growth and enhance shareholder value.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Market Cap of $0.13B reflects the company's current valuation and growth potential within the medical device market.
  • P/E Ratio of 11.31 indicates that the company is potentially undervalued compared to its earnings.
  • Profit Margin of 15.7% demonstrates strong profitability and efficient operations.
  • Gross Margin of 28.3% showcases the company's ability to manage production costs effectively.
  • Beta of -0.02 suggests low volatility compared to the overall market, making it a relatively stable investment.

Rakipler & Benzerleri

Güçlü Yönler

  • Specialized expertise in powered surgical instruments.
  • Strong relationships with medical device OEMs.
  • High profit margin of 15.7%.
  • Comprehensive engineering and regulatory consulting services.

Zayıflıklar

  • Relatively small market capitalization.
  • Dependence on a limited number of OEM customers.
  • Limited geographic diversification.
  • Potential vulnerability to changes in healthcare regulations.

Katalizörler

  • Upcoming: New product launches in the orthopedic and craniomaxillofacial markets planned for late 2026.
  • Ongoing: Increasing demand for minimally invasive surgical procedures driving growth.
  • Ongoing: Expansion of engineering and regulatory consulting services to attract new OEM partners.
  • Upcoming: Potential strategic acquisitions to expand product offerings and market reach.

Riskler

  • Potential: Competition from larger medical device companies with greater resources.
  • Potential: Technological obsolescence requiring continuous innovation and investment.
  • Ongoing: Changes in healthcare regulations and reimbursement policies impacting profitability.
  • Potential: Economic downturns affecting healthcare spending and demand for surgical procedures.
  • Ongoing: Dependence on key OEM customers; loss of a major customer could significantly impact revenue.

Büyüme Fırsatları

  • Expanding Product Line in Orthopedics: Pro-Dex has the opportunity to expand its line of powered surgical instruments specifically for orthopedic procedures. The global orthopedic device market is projected to reach significant value by 2028. By developing innovative instruments for joint replacement, sports medicine, and trauma surgeries, Pro-Dex can capture a larger share of this growing market. This expansion can be achieved through internal R&D and strategic acquisitions of complementary technologies.
  • Penetrating the Craniomaxillofacial Market: The craniomaxillofacial (CMF) device market is another high-growth area for Pro-Dex. The global CMF market is expected to see substantial growth, driven by increasing demand for reconstructive surgeries and trauma care. Pro-Dex can leverage its existing expertise in powered surgical instruments to develop specialized tools for CMF procedures, targeting both reconstructive and aesthetic applications. Strategic partnerships with CMF surgeons and hospitals will be crucial for market penetration.
  • Leveraging Engineering and Regulatory Consulting Services: Pro-Dex's engineering and regulatory consulting services provide a significant growth opportunity. Medical device companies often require specialized expertise to navigate the complex regulatory landscape and develop innovative products. By expanding its consulting services, Pro-Dex can generate additional revenue streams and strengthen its relationships with OEM partners. This includes offering services related to FDA submissions, quality system compliance, and product design optimization.
  • Geographic Expansion into Emerging Markets: Pro-Dex can pursue geographic expansion into emerging markets, where healthcare spending is increasing and demand for advanced surgical technologies is growing. Countries in Asia-Pacific and Latin America offer significant growth potential. Establishing strategic partnerships with local distributors and healthcare providers will be essential for successful market entry. Adapting product offerings to meet the specific needs of these markets will also be crucial.
  • Strategic Acquisitions of Complementary Technologies: Pro-Dex can pursue strategic acquisitions of companies with complementary technologies or product lines. This can accelerate its growth and expand its market reach. Potential acquisition targets include companies specializing in surgical navigation systems, robotic surgery platforms, or advanced materials for medical devices. These acquisitions can enhance Pro-Dex's competitive position and create synergies across its existing business units.

Fırsatlar

  • Expanding product line in orthopedics and craniomaxillofacial markets.
  • Geographic expansion into emerging markets.
  • Strategic acquisitions of complementary technologies.
  • Increasing demand for minimally invasive surgical procedures.

Tehditler

  • Competition from larger medical device companies.
  • Technological obsolescence.
  • Changes in healthcare regulations and reimbursement policies.
  • Economic downturns affecting healthcare spending.

Rekabet Avantajları

  • Specialized expertise in powered surgical instrument design and manufacturing.
  • Strong relationships with medical device OEMs.
  • Comprehensive service offerings including engineering and regulatory consulting.
  • Proprietary technology and intellectual property in surgical instrument design.

PDEX Hakkında

Founded in 1978 and headquartered in Irvine, California, Pro-Dex, Inc. has established itself as a key player in the medical device industry. The company designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers (OEMs) worldwide. Pro-Dex's core offerings include autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers. These instruments are primarily utilized in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its instrument manufacturing, Pro-Dex provides comprehensive engineering, quality, and regulatory consulting services, adding value for its OEM partners. Additionally, the company manufactures and sells rotary air motors to a diverse range of industries, diversifying its revenue streams. Pro-Dex's commitment to innovation and quality has enabled it to build strong relationships with leading medical device companies, solidifying its position in the competitive surgical instrument market. The company's evolution from a rotary air motor manufacturer to a specialized surgical instrument provider demonstrates its adaptability and strategic focus on high-growth sectors within the medical device landscape.

Ne Yaparlar

  • Designs and develops powered surgical instruments.
  • Manufactures autoclavable, battery-powered, and electric surgical drivers.
  • Produces multi-function surgical shavers.
  • Serves the orthopedic market with specialized surgical tools.
  • Provides instruments for thoracic surgical procedures.
  • Offers solutions for craniomaxillofacial surgeries.
  • Delivers engineering, quality, and regulatory consulting services.
  • Manufactures and sells rotary air motors to various industries.

İş Modeli

  • Designs and manufactures powered surgical instruments for medical device OEMs.
  • Generates revenue through the sale of surgical instruments and rotary air motors.
  • Provides engineering, quality, and regulatory consulting services for additional income.
  • Focuses on building long-term relationships with medical device companies.

Sektör Bağlamı

Pro-Dex operates within the medical instruments and supplies industry, a sector characterized by continuous innovation and increasing demand for advanced surgical technologies. The global medical devices market is projected to reach significant growth in the coming years, driven by an aging population, rising healthcare expenditures, and technological advancements. Pro-Dex competes with companies that offer surgical instruments and related services. Key competitors include APYX, CGTX, GLSI, IXHL, and LUCD. Pro-Dex differentiates itself through its focus on powered surgical instruments and its comprehensive service offerings, including engineering and regulatory consulting.

Kilit Müşteriler

  • Medical device original equipment manufacturers (OEMs).
  • Hospitals and surgical centers using their instruments.
  • Various industries purchasing rotary air motors.
  • Orthopedic surgeons and medical professionals.
AI Güveni: 72% Güncellendi: 9 Şub 2026

Finansallar

Grafik & Bilgi

Pro-Dex, Inc. (PDEX) hisse senedi fiyatı: $47.95 (+1.41, +3.03%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

PDEX için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

PDEX için Wall Street fiyat hedefi analizi.

MoonshotScore

59/100

Bu puan ne anlama geliyor?

MoonshotScore, PDEX'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

Pro-Dex, Inc. Hissesi: Cevaplanan Temel Sorular

PDEX için değerlendirilmesi gereken temel faktörler nelerdir?

Pro-Dex, Inc. (PDEX) şu anda yapay zeka skoru 59/100, orta puanı gösteriyor. Hisse 13.7x F/K oranıyla işlem görüyor, S&P 500 ortalamasının (~20-25x) altında, potansiyel değer sinyali. Temel güçlü yan: Specialized expertise in powered surgical instruments.. İzlenmesi gereken birincil risk: Potential: Competition from larger medical device companies with greater resources.. Bu bir finansal tavsiye değildir.

PDEX MoonshotScore'u nedir?

PDEX şu anda MoonshotScore'da 59/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

PDEX verileri ne sıklıkla güncellenir?

PDEX fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler PDEX hakkında ne diyor?

PDEX için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

PDEX'a yatırım yapmanın riskleri nelerdir?

PDEX için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Competition from larger medical device companies with greater resources.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

PDEX'ın P/E oranı nedir?

Pro-Dex, Inc. (PDEX)'nın son P/E oranı 13.7, ki bu da piyasa ortalamasının altında, bu da göreli değeri gösterebilir. P/E (fiyat-kazanç) oranı, hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Bağlam için bunu sektördeki emsallerle ve S&P 500 ortalamasıyla (~20-25x) karşılaştırın. Yüksek bir P/E beklenen gelecekteki büyümeyi yansıtabilirken, düşük bir P/E değer düşüklüğünü veya azalan kazançları gösterebilir. Bu bir finansal tavsiye değildir.

PDEX aşırı değerli mi, yoksa düşük değerli mi?

Pro-Dex, Inc. (PDEX)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. P/E oranı 13.7. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

PDEX'ın temettü verimi nedir?

Pro-Dex, Inc. (PDEX) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Financial data is based on the most recent available information.
  • Market projections are based on industry reports and analyst estimates.
  • Competitive landscape analysis is based on publicly available information.
Veri Kaynakları

Popüler Hisseler